| Symbol | RAPH |
|---|---|
| Name | RAPHAEL PHARMACEUTICAL INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 6803605 Israel 4 Lui Paster |
| Telephone | (+972) 52-775-5072 |
| Fax | — |
| — | |
| Website | http://www.raphaelpharmaceutical.com/ |
| Incorporation | US |
| Incorporated On | 2007 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC;NASDAQ |
| Auditor | Elkana Amitai CPA; |
| Audit Status | AUDITED |
| Reporting Status | U.S. Reporting: SEC Reporting |
| CIK | 0001415397 |
| Description | Discovery and Clinical development of life -improving drug therapies based on Cannabinoids , including cannabidiol oil. Additional info from OTC: |
Raphael Pharmaceutical Announces Filing of Provisional Patent Application for the Treatment of Neutrophil-Dominant Autoimmune Diseases, Including Rheumatoid Arthritis (RA)
Read moreRaphael Pharmaceutical Announces Positive Proof-of-Concept Clinical Study Results for the Company’s Cannabinoid-Based Formula for the Treatment of Rheumatoid Arthritis
Read moreOTCQB symbol attribute type Security_Name was changed. Previous value: -. New value: RAPHAEL PHARMACEUTICL INC.
Read moreOTCQX U.S. Premier symbol attribute type Security_Name was changed. Previous value: CONSUMERS BANCORP INC. New value: RAPHAEL PHARMACEUTICL INC.
Read more